---
figid: PMC6720185__ijms-20-04068-g001
figlink: /pmc/articles/PMC6720185/figure/ijms-20-04068-f001/
number: Figure 1
caption: 'Stress and depression drive an increase in corticotropin releasing factor
  (CRF) that activates mucosal mast cells and leads to an increase in gut permeability,
  coupled to gut dysbiosis and decreased butyrate production. This drives alterations
  in the gut-liver and gut-cardiac axes, with a decrease in butyrate’s histone deacetylase
  (HDAC) inhibitory activity regulating CYP1B1. Increased gut permeability also drives
  an increase in oxidative stress and pro-inflammatory cytokines, which activate tryptophan
  2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO), leading to a driving
  of tryptophan down the kynurenine pathway, with a resultant decrease in serotonin,
  N-acetylserotonin (NAS) and melatonin synthesis. An increase in the NAS/melatonin
  ratio from CYP1B1 and probably mGluRgpI, P2Y1 receptor, CYP2C19 and O-demethylation
  leads to NAS activation of TrkB, as well as brain-derived neurotropic factor (BDNF)
  induction, in turn increasing cyclic adenosine 3′,5′-monophosphate (cAMP)-response
  element binding protein (CREB) and the mitogen-activated protein kinase (MAPK) pathways,
  which all contribute to left ventricular hypertrophy (LVH). The suppression of melatonin
  drives alterations in mitochondria, including via melatonin’s interactions with
  the sirtuins and PGC-1α, with consequences for IDH2 and AMPK-mTOR regulation of
  mitochondria. Alterations in the gut drive changes in the gut-liver and gut-cardiac
  axes that, along with kynurenine activation of the AhR raises CYP1B1 levels. CYP1B1
  may also contribute to LVH via the hydroxyeicosatetraenoic acids (HETEs) and 6β-HT.
  A number of microRNAs known to be altered in LVH, including miR-7, miR-375 and miR-451,
  all act to regulate 14-3-3 and therefore the stabilization of AANAT at the start
  of the melatonergic pathway. Similar processes can underpin hypertension, which
  is the major driver of LVH. 6β-HT: 6β-hydroxytestosterone; AANAT: aralkylamine N-acetyltransferase;
  AhR; aryl hydrocarbon receptor; AMPK: AMP-activated protein kinase; ASMT: acetylserotonin
  O-methyltransferase; BDNF: brain derived neurotrophic factor; CREB: cyclic adenosine
  3′,5′-monophosphate (cAMP)-response element binding protein; CRF: corticotrophin
  releasing factor; CYP: Cytochrome P450; E2: estrogen; GLUT1: glucose transporter
  1; HDAC: histone deacetylase; HETEs: hydroxyeicosatetraenoic acids; IDO: indoleamine
  2,3-dioxygenase; KAT: kynurenine aminotransferase; LVH: left ventricular hypertrophy;
  MAPK: mitogen activated protein kinases; mGluR: metabotropic glutamate receptor;
  Mito: mitochondria; NAS: N-acetylserotonin; P2Y1: purinergic receptor; PARP: poly-(ADP-ribose)
  polymerase; PGC-1α: peroxisome proliferator-activated receptor gamma coactivator
  1-alpha; S1P: sphingosine-1-phosphate; TDO: tryptophan 2,3-dioxygenase; TrkB: tyrosine
  receptor kinase B. Arrows indicate activation; T-bar indicates inhibition.'
pmcid: PMC6720185
papertitle: 'Left Ventricular Hypertrophy: Roles of Mitochondria CYP1B1 and Melatonergic
  Pathways in Co-Ordinating Wider Pathophysiology.'
reftext: George Anderson, et al. Int J Mol Sci. 2019 Aug;20(16):4068.
pmc_ranked_result_index: '232806'
pathway_score: 0.8641488
filename: ijms-20-04068-g001.jpg
figtitle: Stress and depression drive an increase in corticotropin releasing factor
  (CRF) that activates mucosal mast cells and leads to an increase in gut permeability,
  coupled to gut dysbiosis and decreased butyrate production
year: '2019'
organisms: Homo sapiens
ndex: d29ee8a5-df18-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6720185__ijms-20-04068-g001.html
  '@type': Dataset
  description: 'Stress and depression drive an increase in corticotropin releasing
    factor (CRF) that activates mucosal mast cells and leads to an increase in gut
    permeability, coupled to gut dysbiosis and decreased butyrate production. This
    drives alterations in the gut-liver and gut-cardiac axes, with a decrease in butyrate’s
    histone deacetylase (HDAC) inhibitory activity regulating CYP1B1. Increased gut
    permeability also drives an increase in oxidative stress and pro-inflammatory
    cytokines, which activate tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase
    (IDO), leading to a driving of tryptophan down the kynurenine pathway, with a
    resultant decrease in serotonin, N-acetylserotonin (NAS) and melatonin synthesis.
    An increase in the NAS/melatonin ratio from CYP1B1 and probably mGluRgpI, P2Y1
    receptor, CYP2C19 and O-demethylation leads to NAS activation of TrkB, as well
    as brain-derived neurotropic factor (BDNF) induction, in turn increasing cyclic
    adenosine 3′,5′-monophosphate (cAMP)-response element binding protein (CREB) and
    the mitogen-activated protein kinase (MAPK) pathways, which all contribute to
    left ventricular hypertrophy (LVH). The suppression of melatonin drives alterations
    in mitochondria, including via melatonin’s interactions with the sirtuins and
    PGC-1α, with consequences for IDH2 and AMPK-mTOR regulation of mitochondria. Alterations
    in the gut drive changes in the gut-liver and gut-cardiac axes that, along with
    kynurenine activation of the AhR raises CYP1B1 levels. CYP1B1 may also contribute
    to LVH via the hydroxyeicosatetraenoic acids (HETEs) and 6β-HT. A number of microRNAs
    known to be altered in LVH, including miR-7, miR-375 and miR-451, all act to regulate
    14-3-3 and therefore the stabilization of AANAT at the start of the melatonergic
    pathway. Similar processes can underpin hypertension, which is the major driver
    of LVH. 6β-HT: 6β-hydroxytestosterone; AANAT: aralkylamine N-acetyltransferase;
    AhR; aryl hydrocarbon receptor; AMPK: AMP-activated protein kinase; ASMT: acetylserotonin
    O-methyltransferase; BDNF: brain derived neurotrophic factor; CREB: cyclic adenosine
    3′,5′-monophosphate (cAMP)-response element binding protein; CRF: corticotrophin
    releasing factor; CYP: Cytochrome P450; E2: estrogen; GLUT1: glucose transporter
    1; HDAC: histone deacetylase; HETEs: hydroxyeicosatetraenoic acids; IDO: indoleamine
    2,3-dioxygenase; KAT: kynurenine aminotransferase; LVH: left ventricular hypertrophy;
    MAPK: mitogen activated protein kinases; mGluR: metabotropic glutamate receptor;
    Mito: mitochondria; NAS: N-acetylserotonin; P2Y1: purinergic receptor; PARP: poly-(ADP-ribose)
    polymerase; PGC-1α: peroxisome proliferator-activated receptor gamma coactivator
    1-alpha; S1P: sphingosine-1-phosphate; TDO: tryptophan 2,3-dioxygenase; TrkB:
    tyrosine receptor kinase B. Arrows indicate activation; T-bar indicates inhibition.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK9
  - YWHAQ
  - MAPK10
  - AHR
  - MAPK11
  - CREM
  - AANAT
  - ATF1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREB5
  - CYP1B1
  - ASMT
  - CREB3L1
  - MAPK1
  - MAPK3
  - MAPK8
  - PARP3
  - PARP16
  - PARP6
  - PARP11
  - PARP12
  - MAPK12
  - MAPK13
  - GRM5
  - CYP2C19
  - IDO1
  - MAPK14
  - CREB3
  - CREB1
  - ATF2
  - PARP2
  - PPARGC1A
  - PTPN11
  - IDH2
  - PARP8
  - TNKS2
  - PARP9
  - PARP10
  - TNKS
  - BDNF
  - LILRB1
  - P2RY1
  - PARP1
  - PARP14
  - NTRK2
  - TES
  - PARP15
  - TDO2
  - PARP4
  - TIPARP
  - Tryptophan
  - 5-hydroxytryptophan
  - Kynurenine
  - Kynurenic Acid
  - Serotonin
  - N-acetylserotonin
  - 6B-HT
  - Melatonin
  - Butyrate
  - Depression
  - Hypertrophy
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: 14-3-3
  symbol: 14-3-3
  source: hgnc_alias_symbol
  hgnc_symbol: YWHAQ
  entrez: '10971'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: AhR
  symbol: AHR
  source: hgnc_symbol
  hgnc_symbol: AHR
  entrez: '196'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: AANAT
  symbol: AANAT
  source: hgnc_symbol
  hgnc_symbol: AANAT
  entrez: '15'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: CYP1B1
  symbol: CYP1B1
  source: hgnc_symbol
  hgnc_symbol: CYP1B1
  entrez: '1545'
- word: ASMT
  symbol: ASMT
  source: hgnc_symbol
  hgnc_symbol: ASMT
  entrez: '438'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: mGluR5
  symbol: MGLUR5
  source: hgnc_alias_symbol
  hgnc_symbol: GRM5
  entrez: '2915'
- word: CYP2C19
  symbol: CYP2C19
  source: hgnc_symbol
  hgnc_symbol: CYP2C19
  entrez: '1557'
- word: IDO
  symbol: IDO
  source: hgnc_prev_symbol
  hgnc_symbol: IDO1
  entrez: '3620'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PGC-1a
  symbol: PGC-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: Shp2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: Sirtuins,IDH2
  symbol: IDH2
  source: hgnc_symbol
  hgnc_symbol: IDH2
  entrez: '3418'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: miR-7
  symbol: MIR-7
  source: hgnc_alias_symbol
  hgnc_symbol: LILRB1
  entrez: '10859'
- word: P2RY1
  symbol: P2RY1
  source: hgnc_symbol
  hgnc_symbol: P2RY1
  entrez: '5028'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: TrkB
  symbol: TRKB
  source: hgnc_alias_symbol
  hgnc_symbol: NTRK2
  entrez: '4915'
- word: НЕTES
  symbol: TES
  source: hgnc_symbol
  hgnc_symbol: TES
  entrez: '26136'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: TDO
  symbol: TDO
  source: hgnc_alias_symbol
  hgnc_symbol: TDO2
  entrez: '6999'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PARP,
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
chemicals:
- word: Tryptophan
  source: ''
  identifier: ''
- word: 5-hydroxytryptophan
  source: ''
  identifier: ''
- word: Kynurenine
  source: MESH
  identifier: C029366
- word: Kynurenic Acid
  source: MESH
  identifier: D007736
- word: Serotonin
  source: MESH
  identifier: D012701
- word: N-acetylserotonin
  source: MESH
  identifier: C006389
- word: 6B-HT
  source: MESH
  identifier: D012701
- word: Melatonin
  source: MESH
  identifier: D008550
- word: Butyrate
  source: MESH
  identifier: D002087
diseases:
- word: Depression
  source: MESH
  identifier: D000275
- word: Hypertrophy
  source: MESH
  identifier: D006984
---
